Robert J. Kammer, Director at HARROW HEALTH, INC. (HROW), sold 6,500 shares at $6.89 ($45K) on 2019-08-12, disclosed to the SEC on 2019-08-14.
Scheduled sale ($45k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HROW | SELL | 2019-09-11 | $37K | — | Filing → |
| HROW | SELL | 2019-07-16 | $51K | — | Filing → |
| HROW | SELL | 2019-06-05 | $58K | — | Filing → |